Ixekizumab successfully treated severe pityriasis rubra pilaris after COVID‐19 vaccination
Abstract Pityriasis rubra pilaris is an inflammatory dermatologic disorder of unknown cause. We report a 67‐year‐old man with Pityriasis rubra pilaris might induced by COVID‐19 vaccination. The patient developed the lesions after the first dose of vaccine and significantly aggravated after the secon...
Saved in:
Main Authors: | Ya‐ting Liu (Author), Shang‐shang Wang (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2023-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pityriasis rubra pilaris following COVID-19 vaccination successfully treated with ixekizumab
by: Patricia Zhao, BS, et al.
Published: (2023) -
Successful Treatment of Pityriasis Rubra Pilaris with Ixekizumab
by: Kathrin Hanfstingl, et al.
Published: (2018) -
Pityriasis rubra pilaris rapidly cleared with ixekizumab in an HIV-positive patient
by: Allison Kranyak, MD, et al.
Published: (2022) -
Pityriasis rubra pilaris after COVID-19 vaccination: successful treatment with ustekinumab
by: Bárbara Vieira Granja, et al.
Published: (2024) -
Pityriasis Rubra Pilaris refractory to ustekinumab successfully treated with guselkumab
by: João Teixeira, et al.
Published: (2024)